EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Evaluation of a Pilot Medication-Assisted Therapy Program in Kazakhstan: Successes, Challenges, and Opportunities for Scaleup

Azizbek A Boltaev, Anna P Deryabina, Almas Kusainov, Andrea A Howard

Advances in Preventive Medicine · 2012

DOI: 10.1155/2012/308793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Preventive Medicine, 2012. Verfasst von Azizbek A Boltaev und 3 weiteren Autor:innen. Beteiligte Einrichtung: ICAP, Mailman School of Public Health, Columbia University, New York, NY, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Ministry of Health of the Republic of Kazakhstan, Republican AIDS Center, Centers for Disease Control and Prevention.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study Aims . Evaluate the quality and effectiveness of the medication-assisted therapy (MAT) pilot in Kazakhstan and review implementation context and related challenges.

Methods

We performed a desk review of MAT policy and program documents and reviewed medical records at three MAT sites in Kazakhstan. MAT patients ( n = 93 ) were interviewed to assess their perceptions of the program and its impact on their health, criminal, drug use, and HIV risk related behaviors as well as expenditures on nonprescribed psychoactive drugs. Persons injecting drugs who are not in treatment, MAT program staff, and other stakeholders were interviewed to obtain their perspectives on MAT.

Results

Legislation supports introducing MAT as a standard of care for treatment of opioid dependence; however, its progress has been hampered by active opposition. Inadequate access and coverage, insufficient supply management, scarce infrastructure of narcological facilities, limited opportunities for staff development, and restrictive methadone dispensing policies compromise the quality of the intervention and limit its potential benefits. There were significant reductions in criminal, drug use, and HIV risk related behaviors in patients receiving MAT.

Conclusions

The MAT pilot in Kazakhstan demonstrated its feasibility and effectiveness in the local context and is recommended for scaleup throughout the country.

Autor:innen und Institutionen

  • ICAP, Mailman School of Public Health, Columbia University, New York, NY, USA.

Förderung

  • Ministry of Health of the Republic of Kazakhstan
  • Republican AIDS Center
  • Centers for Disease Control and Prevention

Zitieren

APA

Boltaev, A. A., Deryabina, A. P., Kusainov, A., & Howard, A. A. (2012). Evaluation of a Pilot Medication-Assisted Therapy Program in Kazakhstan: Successes, Challenges, and Opportunities for Scaleup. Advances in Preventive Medicine. https://doi.org/10.1155/2012/308793

Vancouver

Boltaev AA, Deryabina AP, Kusainov A, Howard AA. Evaluation of a Pilot Medication-Assisted Therapy Program in Kazakhstan: Successes, Challenges, and Opportunities for Scaleup. Advances in Preventive Medicine. 2012. doi:10.1155/2012/308793

BibTeX
@article{Boltaev2012,
  author = {Boltaev, Azizbek A and Deryabina, Anna P and Kusainov, Almas and Howard, Andrea A},
  title = {Evaluation of a Pilot Medication-Assisted Therapy Program in Kazakhstan: Successes, Challenges, and Opportunities for Scaleup},
  journal = {Advances in Preventive Medicine},
  year = {2012},
  doi = {10.1155/2012/308793}
}
Kostenlos starten →